Medical expulsive therapy for distal ureteral stones

Drugs

Volumn 69, Issue 6, 2009, Pages 677-692

  Tzortzis, Vassilios ^a   Mamoulakis, Charalampos ^b   Rioja, Jorge ^b   Gravas, Stavros ^a   Michel, Martin C ^b   De La Rosette, Jean J M C H ^b,c  

^a UNIVERSITY OF THESSALY   (Greece)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

5 METHYLURAPIDIL; AESCULUS HIPPOCASTANUM EXTRACT; ALFUZOSIN; BUPRENORPHINE; CELECOXIB; CORTICOSTEROID DERIVATIVE; DEFLAZACORT; DEXTROPROPOXYPHENE; DICLOFENAC; DOXAZOSIN; INDOMETACIN; KETOROLAC; METHYLPREDNISOLONE; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NIFEDIPINE; PHLOROGLUCINOL; PLACEBO; PREDNISOLONE; PROSTAGLANDIN; TAMSULOSIN; TENOXICAM; TERAZOSIN; TOLTERODINE;

ADJUVANT THERAPY; ASTHENIA; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DIARRHEA; DIZZINESS; DROWSINESS; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; DYSPEPSIA; EJACULATION; ERYTHEMA; EUPHORIA; EXTRACORPOREAL LITHOTRIPSY; HEART PALPITATION; HUMAN; HYPOTENSION; INCIDENCE; KIDNEY COLIC; LOW DRUG DOSE; MALAISE; MOUTH EDEMA; NAUSEA; NAUSEA AND VOMITING; ORTHOSTATIC HYPOTENSION; PREVALENCE; RECURRENT DISEASE; REVIEW; SIDE EFFECT; STOMACH PAIN; SYNCOPE; UNSPECIFIED SIDE EFFECT; URETER PERISTALSIS; URETER STONE; URINARY TRACT OBSTRUCTION; UROLITHIASIS; UROSEPSIS; VOMITING;

ADRENAL CORTEX HORMONES; ADRENERGIC ALPHA-ANTAGONISTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CALCIUM CHANNEL BLOCKERS; CHOLINERGIC ANTAGONISTS; CLINICAL TRIALS AS TOPIC; COST-BENEFIT ANALYSIS; DRUG THERAPY, COMBINATION; HUMANS; URETERAL CALCULI;

EID: 65949116787     PISSN: 00126667     EISSN: 00126667     Source Type: Journal    
DOI: 10.2165/00003495-200969060-00003     Document Type: Review

References (82)

1. Preminger GM, Tiselius HG, Assimos DG, et al. 2007 guideline for the management of ureteral calculi. Eur Urol 2007 Dec; 52 (6): 1610-31.
2. Miller OF, Kane CJ. Time to stone passage for observed ureteral calculi: a guide for patient education. J Urol 1999 Sep; 162 (3 Pt 1): 688-90.
3. Laird JM, Roza C, Cervero F. Effects of artificial calculosis on rat ureter motility: peripheral contribution to the pain of ureteric colic. Am J Physiol 1997 May; 272 (5 Pt 2): R1409-16.
4. 2+- ATPase inhibitor, cyclopiazonic acid, on electromechanical coupling in the guinea-pig ureter. Br J Pharmacol 1995 Jan; 114 (1): 127-37.
5. Morita T, Wada I, Saeki H, et al. Ureteral urine transport: changes in bolus volume, peristaltic frequency, intraluminal pressure and volume of flow resulting from autonomic drugs. J Urol 1987 Jan; 137 (1): 132-5.
6. Ramello A, Vitale C, Marangella M. Epidemiology of nephrolithiasis. J Nephrol 2000; 13 Suppl. 3: S45-50.
7. Stamatelou KK, Francis ME, Jones CA, et al. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int 2003 May; 63 (5): 1817-23.
8. Amato M, Lusini ML, Nelli F. Epidemiology of nephrolithiasis today. Urol Int 2004; 72 Suppl. 1: 1-5.
9. Ahlstrand C, Tiselius HG. Recurrences during a 10-year follow-up after first renal stone episode. Urol Res 1990; 18 (6): 397-9.
10. Trinchieri A, Ostini F, Nespoli R, et al. A prospective study of recurrence rate and risk factors for recurrence after a first renal stone. J Urol 1999 Jul; 162 (1): 27-30.
11. Ibrahim AI, Shetty SD, Awad RM, et al. Prognostic factors in the conservative treatment of ureteric stones. Br J Urol 1991 Apr; 67 (4): 358-61.
12. Hübner WA, Irby P, Stoller ML. Natural history and current concepts for the treatment of small ureteral calculi. Eur Urol 1993; 24 (2): 172-6.
13. Preminger GM, Tiselius HG, Assimos DG, et al. 2007 guideline for the management of ureteral calculi. J Urol 2007 Dec; 178 (6): 2418-34.
14. Sahin A, Erdemli I, Bakkaloglu M, et al. The effect of nifedipine and verapamil on rhythmic contractions of human isolated ureter. Arch Int Physiol Biochim Biophys 1993 Sep-Oct; 101 (5): 245-7.
15. Nemeth L, O'Briain DS, Puri P. Demonstration of neuronal networks in the human upper urinary tract using confocal laser scanning microscopy. J Urol 2001 Jul; 166 (1): 255-8.
16. Weiss RM. Physiology of the upper urinary tract. Semin Urol 1987 Aug; 5 (3): 148-54.
17. Cole RS, Fry CH, Shuttleworth KE. The action of the prostaglandins on isolated human ureteric smooth muscle. Br J Urol 1988 Jan; 61 (1): 19-26.
18. Santis WF, Peters CA, Yalla SV, et al. Ureteral function is modulated by a local renin-angiotensin system. J Urol 2003 Jul; 170 (1): 259-63.
19. Hong SK, Kwak C, Chang Jeong B, et al. Involvement of Rho-kinase in the contractile mechanism of human ureteral smooth muscle.NeurourolUrodyn 2005; 24 (2): 136-41.
20. Beach MA, Mauro LS. Pharmacologic expulsive treatment of ureteral calculi. Ann Pharmacother 2006 Jul-Aug; 40 (7-8): 1361-8.
21. Yamaguchi K,Minei S, Yamazaki T, et al. Characterization of ureteral lesions associated with impacted stones. Int J Urol 1999 Jun; 6 (6): 281-5.
22. Floyd RV, Borisova L, Bakran A, et al. Morphology, calcium signalling and mechanical activity in human ureter. J Urol 2008 Jul; 180 (1): 398-405.
23. Davenport K, Timoney AG, Keeley FX. A comparative in vitro study to determine the beneficial effect of calciumchannel and alpha(1)-adrenoceptor antagonism on human ureteric activity. BJU Int 2006 Sep; 98 (3): 651-5.
24. Borghi L, Meschi T, Amato F, et al. Nifedipine and methylprednisolone in facilitating ureteral stone passage: a randomized, double-blind, placebo-controlled study. J Urol 1994 Oct; 152 (4): 1095-8.
25. Cooper JT, Stack GM, Cooper TP. Intensive medical management of ureteral calculi. Urology 2000 Oct 1; 56 (4): 575-8.
26. Porpiglia F, Destefanis P, Fiori C, et al. Effectiveness of nifedipine and deflazacort in the management of distal ureter stones. Urology 2000 Oct 1; 56 (4): 579-82.
27. Saita A, Bonaccorsi A, Marchese F, et al. Our experience with nifedipine and prednisolone as expulsive therapy for ureteral stones. Urol Int 2004; 72 (1 Suppl.): 43-5.
28. Porpiglia F, Ghignone G, Fiori C, et al. Nifedipine versus tamsulosin for the management of lower ureteral stones. J Urol 2004 Aug; 172 (2): 568-71.
29. Dellabella M, Milanese G, Muzzonigro G. Randomized trial of the efficacy of tamsulosin, nifedipine and phloroglucinol in medical expulsive therapy for distal ureteral calculi. J Urol 2005 Jul; 174 (1): 167-72.
30. Porpiglia F, Destefanis P, Fiori C, et al. Role of adjunctive medical therapy with nifedipine and deflazacort after extracorporeal shock wave lithotripsy of ureteral stones. Urology 2002 Jun; 59 (6): 835-8.
31. Hollingsworth JM, Rogers MA, Kaufman SR, et al. Medical therapy to facilitate urinary stone passage: a meta-analysis. Lancet 2006 Sep; 368 (9542): 1171-9.
32. Singh A, Alter HJ, Littlepage A. A systematic review of medical therapy to facilitate passage of ureteral calculi. Ann Emerg Med 2007 Nov; 50 (5): 552-63.
33. Skrekas T, Liapidis D, Kalantzis A, et al. Increasing the success rate of medical therapy for expulsion of distal ureteral stone using adjunctive treatment with calcium channel blocker. In: XVIIIth Congress of the European Association of Urology; 2003 Mar 12-15; Madrid. Eur Urol Suppl 2003 Feb; 2 (1 Suppl.): 82.
34. Taghavi R, Darabi MR, Tavakoli K, et al. Survey of the effect of tamsulosin and nifedipine on facilitating juxtavesical ureteral stone passage. In: 23rd World Congress on Endourology and SWL 21st Basic Research Symposium, Aug 23-26; Amsterdam. J Endourol 2005 July; 19 (1 Suppl.): A9.
35. Staerman F, Bryckaert PE, Colin J, et al. Nifedipine in the medical treatment of symptomatic distal ureteral calculi. In: XVth Congress of the European Association of Urology, Apr 12-15; Brussels. Eur Urol 2000 March; 37 (2 Suppl.): 110.
36. Le Lorier J, Gre'goire G, Benhaddad A, et al. Discrepancies between meta-analyses and subsequent large randomized, controlled trials. N Engl J Med 1997 Aug; 337 (8): 536-42.
37. Malin Jr JM, Deane RF, Boyarsky S. Characterisation of adrenergic receptors in human ureter. Br J Urol 1970 Apr; 42 (2): 171-4.
38. Weiss RM, Bassett AL, Hoffman BF. Adrenergic innervation of the ureter. Invest Urol 1978 Sep; 16 (2): 123-7.
39. Sigala S, Dellabella M, Milanese G, et al. Evidence for the presence of alpha1 adrenoceptor subtypes in the human ureter. Neurourol Urodyn 2005; 24 (2): 142-8.
40. Cervenákov I, Fillo J, Mardiak J, et al. Speedy elimination of ureterolithiasis in lower part of ureters with the alpha 1-blocker: tamsulosin. Int Urol Nephrol 2002; 34 (1): 25-9.
41. Küpeli B, Irkilata L, Gü rocak S, et al. Does tamsulosin enhance lower ureteral stone clearance with or without shock wave lithotripsy? Urology 2004 Dec; 64 (6): 1111-5.
42. Yilmaz E, Batislam E, Basar MM, et al. The comparison and efficacy of 3 different alpha1-adrenergic blockers for distal ureteral stones. J Urol 2005 Jun; 173 (6): 2010-2.
43. Resim S, Ekerbicer HC, Ciftci A. Role of tamsulosin in treatment of patients with steinstrasse developing after extracorporeal shock wave lithotripsy. Urology 2005 Nov; 66 (5): 945-8.
44. De Sio M, Autorino R, Di Lorenzo G, et al. Medical expulsive treatment of distal ureteral stones using tamsulosin: a single-center experience. J Endourol 2006 Jan; 20 (1): 12-6.
45. Liatsikos EN, Katsakiori PF, Assimakopoulos K, et al. Doxazosin for the management of distal-ureteral stones. J Endourol 2007 May; 21 (5): 538-41.
46. Pedro RN, Hinck B, Hendlin K, et al. Alfuzosin stone expulsion therapy for distal ureteral calculi: a doubleblind, placebo controlled study. J Urol 2008 Jun; 179 (6): 2244-7.
47. Wang CJ, Huang SW, Chang CH. Efficacy of an a1 blocker in expulsive therapy of lower ureteral stones. J Endourol 2008; 22: 41-5.
48. Michel MC, de la Rosette JJMCH. a-Blocker treatment of urolithiasis. Eur Urol 2006 Aug; 50 (2): 213-4.
49. Parsons JK, Hergan LA, Sakamoto K, et al. Efficacy of a-blockers for the treatment of ureteral stones. J Urol 2007 Mar; 177 (3): 983-7.
50. Lojanapiwat B, Kochakarn W, Suparatchatpan N, et al. Effectiveness of low-dose and standard-dose tamsulosin in the treatment of distal ureteric stones: a randomized controlled study. J Int Med Res 2008 May-Jun; 36 (3): 529-36.
51. Autorino R, de Sio M, Damiano R, et al. The use of tamsulosin in the medical treatment of ureteral calculi: where we stand today. Urol Res 2005 Dec; 33 (6): 460-4.
52. Gravina GL, Costa AM, Ronchi P, et al. Tamsulosin treatment increases clinical success rate of single extracorporeal shock wave lithotripsy of renal stones. Urology 2005 Jul; 66 (1): 24-8.
53. Gravas S, Tzortzis V, Karatzas A, et al. The use of tamsulozin as adjunctive treatment after ESWL in patients with distal ureteral stone: do we really need it? Results from a randomised study. Urol Res 2007 Oct; 35 (5): 231-5.
54. Bhagat SK, Chacko NK, Kekre NS, et al. Is there a role for tamsulosin in shock wave lithotripsy for renal and ureteral calculi? J Urol 2007 Jun; 177 (6): 2185-8.
55. Chandrabose KA, Lapetina EG, Schmitges CJ, et al. Action of corticosteroids in regulation of prostaglandin biosynthesis in cultured fibroblasts. Proc Natl Acad Sci U S A 1978 Jan; 75 (1): 214-7.
56. Goppelt-Struebe M. Molecular mechanisms involved in the regulation of prostaglandin biosynthesis by glucocorticoids. Biochem Pharmacol 1997 May 15; 53 (10): 1389-95.
57. Masferrer JL, Seibert K. Regulation of prostaglandin synthesis by glucocorticoids. Receptor 1994; 4 (1): 25-30.
58. Ahmad M, Chaughtai MN, Khan FA. Role of prostaglandin synthesis inhibitors in the passage of ureteric calculus. J Pak Med Assoc 1991 Nov; 41 (11): 268-70.
59. Jerde TJ, Mellon WS, Fischer SM, et al. Suppression of 15-hydroxyprostaglandin dehydrogenase messenger RNA concentration, protein expression, and enzymatic activity during human ureteral obstruction. J Pharmacol Exp Ther 2004 Apr; 309 (1): 398-403.
60. Johns A, Wooster MJ. The inhibitory effects of prostaglandin E1 on guinea-pig ureter. Can J Physiol Pharmacol 1975 Apr; 53 (2): 239-47.
61. Ali M, Angelo-Khattar M, Thulesius L, et al. Urothelial synthesis of prostanoids in the ovine ureter. Urol Res 1998; 26 (3): 171-4.
62. Abrams PH, Feneley RC. The actions of prostaglandins on the smooth muscle of the human urinary tract in vitro. Br J Urol 1975; 47 (7): 909-15.
63. Vermue NA, Den Hertog A. The action of prostaglandins on ureter smooth muscle of guinea-pig. Eur J Pharmacol 1987 Oct 6; 142 (1): 163-7.
64. Andersson KE, Forman A. Effects of prostaglandins on the smooth muscle of the urinary tract. Acta Pharmacol Toxicol (Copenh) 1978; 43 Suppl. 2: 90-5.
65. Lowry PS, Jerde TJ, Bjorling DE, et al. Obstruction alters the effect of prostaglandin E2 on ureteral contractility. J Endourol 2005 Mar; 19 (2): 183-7.
66. Dellabella M, Milanese G, Muzzonigro G. Medicalexpulsive therapy for distal ureterolithiasis: randomized prospective study on role of corticosteroids used in combination with tamsulosin-simplified treatment regimen and health-related quality of life. Urology 2005 Oct; 66 (4): 712-5.
67. Porpiglia F, Vaccino D, Billia M, et al. Corticosteroids and tamsulosin in the medical expulsive therapy for symptomatic distal ureter stones: single drug or association? Eur Urol 2006 Aug; 50 (2): 339-44.
68. Hernández M, Si'monsen U, Prieto D, et al. Different muscarinic receptor subtypes mediating the phasic activity and basal tone of pig isolated intravesical ureter. Br J Pharmacol 1993 Dec; 110 (4): 1413-20.
69. Sakamoto K, Suri D, Rajasekaran M. Characterization of muscarinic receptor subtypes in human ureter. J Endourol 2006 Nov; 20 (11): 939-42.
70. Hernández M, García-Sacristán A, Orensanz LM. Muscarinic binding sites of the pig intravesical ureter. J Auton Pharmacol 1995 Oct; 15 (5): 351-9.
71. Tomiyama Y, Wanajo I, Yamazaki Y, et al. Functional muscarinic cholinoceptors in the isolated canine ureter. Naunyn Schmiedebergs Arch Pharmacol 2003 Apr; 367 (4): 348-52.
72. Tomiyama Y, Wanajo I, Yamazaki Y, et al. Effects of cholinergic drugs on ureteral function in anesthetized dogs. J Urol 2004 Oct; 172 (4 Pt 1): 1520-3.
73. Erturhan S, Erbagci A, Yagci F, et al. Comparative evaluation of efficacy of use of tamsulosin and/or tolterodine for medical treatment of distal ureteral stones. Urology 2007 Apr; 69 (4): 633-6.
74. Nakada SY, Jerde TJ, Jacobson LM, et al. Cyclooxygenase- 2 expression is up-regulated in obstructed human ureter. J Urol 2002 Sep; 168 (3): 1226-9.
75. Nørregaard R, Jensen BL, Topcu SO, et al. Cyclooxygenase type 2 is increased in obstructed rat and human ureter and contributes to pelvic pressure increase after obstruction. Kidney Int 2006 Sep; 70 (5): 872-81.
76. Chaignat V, Danuser H, Stoffel MH, et al. Effects of a nonselective COX inhibitor and selective COX-2 inhibitors on contractility of human and porcine ureters in vitro and in vivo. Br J Pharmacol 2008 Jul; 154 (6): 1297-307.
77. Mastrangelo D, Wisard M, Rohner S, et al. Diclofenac and NS-398, a selective cyclooxygenase-2 inhibitor, decrease agonist-induced contractions of the pig isolated ureter. Urol Res 2000 Dec; 28 (6): 376-82.
78. Jerde TJ, Calamon-Dixon JL, Bjorling DE, et al. Celecoxib inhibits ureteral contractility and prostanoid release. Urology 2005 Jan; 65 (1): 185-90.
79. Laerum E, Ommundsen OE, Grnseth JE, et al. Oral diclofenac in the prophylactic treatment of recurrent renal colic: a double-blind comparison with placebo. Eur Urol 1995; 28 (2): 108-11.
80. Pearle MS, Calhoun EA, Curhan GC. Urologic Diseases in America Project: urolithiasis. J Urol 2005 Mar; 173 (3): 848-57.
81. Lotan Y, Gettman MT, Roehrborn CG, et al. Management of ureteral calculi: a cost comparison and decision making analysis. J Urol 2002 Apr; 167 (4): 1621-9.
82. Bensalah K, Pearle M, Lotan Y. Cost-effectiveness ofmedical expulsive therapy using alpha-blockers for the treatment of distal ureteral stones. Eur Urol 2008 Feb; 53 (2): 411-8.